BMS to pay $19.5 million to settle marketing violations for Abilify; AstraZeneca to cut 700 U.S. jobs; Trump reportedly considering Jim O’Neill to lead FDA
How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans “controlled” launch of CAR-T therapy
The 2017 pipeline report: What to know about next year’s launches
Lilly’s experimental Alzheimer’s drug fails in another trial; two more patients die during trial for Juno’s CAR-T therapy; NEJM launches platform in China
Five things for pharma marketers to know: Tuesday, November 22, 2016
Novartis to delay clinical trials of contact lens for diabetes patients; the ADA calls for hearings on insulin pricing; Vice launches healthcare channel